Log in to save to my catalogue

Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therap...

Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therap...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1722177805

Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index

About this item

Full title

Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index

Publisher

New York: Nature Publishing Group US

Journal title

Nature biotechnology, 2015-07, Vol.33 (7), p.733-735

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

The
in vivo
efficacy of antibody-drug conjugates is enhanced by decreasing their hydrophobicity.
The
in vitro
potency of antibody-drug conjugates (ADCs) increases with the drug-to-antibody ratio (DAR); however, ADC plasma clearance also increases with DAR, reducing exposure and
in vivo
efficacy. Here we show that accelerated cl...

Alternative Titles

Full title

Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1722177805

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1722177805

Other Identifiers

ISSN

1087-0156

E-ISSN

1546-1696

DOI

10.1038/nbt.3212

How to access this item